Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Sep. 30, 2019
Current Assets:
Cash and cash equivalents	$ 30,785	$ 30,361
Available-for-sale securities	30,313	24,931
Accounts receivable, net of allowances of $130 and $200 as of September 30, 2020 and 2019, respectively	7,675	8,993
Contract assets — royalties and license fees	6,108	8,210
Inventories, net	5,966	4,501
Income tax receivable	2,391	558
Prepaids and other	3,370	3,866
Total Current Assets	86,608	81,420
Property and equipment, net	30,103	29,748
Deferred income taxes	7,315	6,176
Intangible assets, net	13,283	14,226
Goodwill	27,185	26,171
Other assets	4,269	2,124
Total Assets	168,763	159,865
Current Liabilities:
Accounts payable	1,515	2,085
Accrued liabilities:
Compensation	6,630	4,581
Accrued other	5,547	4,790
Deferred revenue	5,200	5,553
Contingent consideration		3,200
Total Current Liabilities	18,892	20,209
Deferred revenue, less current portion	10,796	11,628
Other long-term liabilities	8,020	5,512
Total Liabilities	37,708	37,349
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Series A preferred stock — $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock — $.05 par value, 45,000 shares authorized; 13,672 and 13,504 shares issued and outstanding, as of September 30, 2020 and 2019, respectively	684	675
Additional paid-in capital	15,369	10,740
Accumulated other comprehensive income	3,174	396
Retained earnings	111,828	110,705
Total Stockholders’ Equity	131,055	122,516
Total Liabilities and Stockholders’ Equity	$ 168,763	$ 159,865